Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05717582
What this trial is testing

Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment

Who this might be right for
Metastatic Prostate CancerCastration-Sensitive Prostate Cancer
Fudan University 47
Testing effectiveness (Phase 2)UnknownNCT02913859
What this trial is testing

Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital Sestre Milosrdnice 60
Testing effectiveness (Phase 2)Looking for participantsNCT06927635
What this trial is testing

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Who this might be right for
Castrate Resistance Prostate CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 75
Not applicableLooking for participantsNCT05933876
What this trial is testing

The Impact of Radiotherapy on Oligometastatic Cancer

Who this might be right for
MetastasisMetastatic Breast CancerMetastatic Prostate Cancer+2 more
Institut Investigacio Sanitaria Pere Virgili 2,000
Testing effectiveness (Phase 2)Study completedNCT00554918
What this trial is testing

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
University Hospital Birmingham 300
Early research (Phase 1)Study completedNCT02363855
What this trial is testing

Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects

Who this might be right for
Prostatic Neoplasms
Bayer 9
Post-approval studies (Phase 4)Study completedNCT00391690
What this trial is testing

Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Novartis 99
Large-scale testing (Phase 3)Study completedNCT00375648
What this trial is testing

Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer

Who this might be right for
Pain
Novartis Pharmaceuticals 61
Not applicableStudy completedNCT03280420
What this trial is testing

Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to BPH Under Tamsulosin Treatment

Who this might be right for
BPH With Urinary Obstruction
Salem Hassan Salem Mohamed 60
Large-scale testing (Phase 3)Study completedNCT00003162
What this trial is testing

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Who this might be right for
Breast CancerMetastatic CancerPain+1 more
Radiation Therapy Oncology Group 949
Not applicableStudy completedNCT01528774
What this trial is testing

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

Who this might be right for
Melanoma
Wolfram Samlowski 150
Testing effectiveness (Phase 2)Study completedNCT00081159
What this trial is testing

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 80
Not applicableStudy completedNCT00680680
What this trial is testing

Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker

Who this might be right for
Urinary RetentionBenign Prostatic Hyperplasia
Franklin D. Gaylis, MD Inc. 20
Not applicableStudy completedNCT02729103
What this trial is testing

Treatment Patterns in Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Bayer 565
Testing effectiveness (Phase 2)Study completedNCT03655886
What this trial is testing

Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial

Who this might be right for
Prostate Cancer Metastatic
University Hospital, Ghent 43
Large-scale testing (Phase 3)Study completedNCT00869206
What this trial is testing

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Who this might be right for
Breast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell Myeloma+4 more
Alliance for Clinical Trials in Oncology 1,822
Testing effectiveness (Phase 2)Active Not RecruitingNCT04655365
What this trial is testing

Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 50
Testing effectiveness (Phase 2)Ended earlyNCT01816048
What this trial is testing

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Who this might be right for
Prostatic NeoplasmsProstate Cancer
University of Wisconsin, Madison 8
Not applicableWithdrawnNCT02022904
What this trial is testing

Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology

Who this might be right for
Prostate Cancer
Duke University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747
What this trial is testing

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
M.D. Anderson Cancer Center 173
Next Page